Access content directly

aurelie terrier-lenglet

45
Documents

Publications

Le pharmacien clinicien dans l’hôpital de jour d’insuffisance cardiaque : quel impact ?

D. Calvez , E. Vermes , A. Terrier-Lenglet , C. Debanne
Le Pharmacien Clinicien, 2024, 59 (2), pp.e148. ⟨10.1016/j.phacli.2024.04.256⟩
Journal articles hal-04610570v1

Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients

Aurelie Lenglet , Stéphane Jaisson , Philippe Gillery , Souleiman El Balkhi , Sophie Liabeuf
Amino Acids, 2023, 55 (10), pp.1455-1460. ⟨10.1007/s00726-023-03306-0⟩
Journal articles hal-04176949v1
Image document

Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease

Sylvie Perreault , Laurie-Anne Boivin Proulx , Aurélie Lenglet , Ziad Massy , Marc Dorais
World Journal of Nephrology, 2023, 12 (5), pp.132-146. ⟨10.5527/wjn.v12.i5.132⟩
Journal articles hal-04496436v1

Prise en charge médicamenteuse de l’insuffisance cardiaque

Syriane Bouras , Charlotte Debanne , Sophie Membre , Seyhan Denev , Aurélie Terrier
Le Pharmacien Clinicien, 2023, ⟨10.1016/j.phacli.2023.07.004⟩
Journal articles hal-04192616v1

Audit croisé des activités de pharmacie clinique entre deux centres hospitalo-universitaires : retour d’expérience d’une démarche stimulante

Thierry Nai , Marion Fourtage , Anne Feron , Mohammed Belhout , Hugues Bourgeois
Le Pharmacien Clinicien, 2023, ⟨10.1016/j.phacli.2023.07.003⟩
Journal articles hal-04182891v1

Iatrogeny in the elderly: assessment of pharmaceutical interventions in a cardiology department

S. Bouras , Aurélie Terrier-Lenglet , M. Belhout , C. Debanne
International Journal of Clinical Pharmacy, 2022, 44 (6), pp.1536-1537 ; PP105
Journal articles hal-04031745v1

Drugs at risk: assessing pharmacy and medical interns' knowledge of injectable antidiabetics

S. Bouras , Aurélie Terrier-Lenglet , M. Belhout , C. Debanne
International Journal of Clinical Pharmacy, 2022, 44 (6), pp.1536-1537 ; PP106
Journal articles hal-04031740v1

Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation

Sylvie Perreault , Robert Côté , Alice Dragomir , Brian White-Guay , Aurélie Lenglet
PLoS ONE, 2022, 17 (12), pp.e0277744. ⟨10.1371/journal.pone.0277744⟩
Journal articles hal-03890259v1

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation

Sylvie Perreault , Alice Dragomir , Robert Cote , Aurelie Lenglet , Simon De Denus
Frontiers in Pharmacology, 2022, 12, ⟨10.3389/fphar.2021.812018⟩
Journal articles hal-03566157v1

Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study

Amaury Durand , André Gillibert , Sophie Membre , Lisa Mondet , Aurélie Lenglet
FRONTIERS IN PHARMACOLOGY, 2022, 13, ⟨10.3389/fphar.2022.811289⟩
Journal articles hal-04139786v1

Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation

Aurélie Lenglet , Jakub Qazi , Laurie‐anne Boivin Proulx , Catherine Legault , Marc Dorais
Pharmacology Research & Perspectives, 2022, 10 (6), ⟨10.1002/prp2.1012⟩
Journal articles hal-03870121v1

Comparative effectiveness and safety of low versus high dose rivaroxaban and apixaban for atrial fibrillation: A propensity score-matched cohort study

Sylvie Perreault , Alice Dragomir , Robert Cote , Brian White-Guay , Aurélie Lenglet
Pharmacoepidemiology and Drug Safety, 2021, 30 (1, SI), pp.176-177
Journal articles hal-04139787v1

Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer

Aurelie Feral , Mathieu Boone , Virginie Lucas , Céline Bihan , Mohamed Belhout
Journal of Oncology Pharmacy Practice, 2021, 28 (7), pp.1543-1551. ⟨10.1177/10781552211035368⟩
Journal articles hal-03792480v1
Image document

Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease

Aurélie Lenglet , Mohamad Ali Rahali , François Ludovic Sauvage , Sophie Liabeuf , Gabriel Choukroun
Drugs in R&D, 2021, 21 (2), pp.231-238. ⟨10.1007/s40268-021-00350-7⟩
Journal articles hal-03287335v1

Comparative effectiveness and safety of high-dose rivaroxaban and apixaban for atrial fibrillation: A propensity score-matched cohort study

Sylvie Perreault , Alice Dragomir , Robert Cote , Aurelie Lenglet , Brian White-Guay
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021, 41 (4), pp.379-393. ⟨10.1002/phar.2509⟩
Journal articles hal-03584692v1

Noma prevalence study, Northwest Nigeria 2018

E. Farley , O. J. Modupe , J. Schuurmans , F. Saleh , C. Ihekweazu
Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019, 113 (1, SI), pp.S68-S69
Journal articles hal-04139788v1

Risk factors for diagnosed noma in northwest Nigeria: a case-control study

E. Farley , Aurélie Lenglet , C. Ariti , N. M. Jiya , A. S. Adetunji
Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019, 113 (1, SI), pp.S227-S228
Journal articles hal-04139789v1

Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?

Aurelie Lenglet , Nicolas Fabresse , Meline Taupin , Cathy Gomila , Sophie Liabeuf
Drugs, 2019, 79 (8), pp.855-862. ⟨10.1007/s40265-019-01118-9⟩
Journal articles hal-03578810v1

Using of pharmaceutical intelligence in a new software to improve pharmaceutical analysis of anticoagulants

S. Membre , C. Mabille , L. Mondet , M. Belhout , Aurélie Terrier-Lenglet
International Journal of Clinical Pharmacy, 2019, 41 (5), pp.1388-1389
Journal articles hal-03584688v1

Randomised, open label multicentre, non-inferiority clinical trial for new treat modalities for cutaneous leishmaniasis caused by leishmania tropica

S. Kamink , Aurélie Lenglet , T. Pylypenko , T. Jensen , S. Ashraf
Transactions of The Royal Society of Tropical Medicine and Hygiene, 2019, 113 (1, SI), pp.S157
Journal articles hal-04139790v1

CONSIGNELA: A multidisciplinary patient-centered project to improve drug prescription comprehension and execution in elderly people and parkinsonian patients

Gregory Moro Puppi Wanderley , Élodie Vandenbergh , Marie-Hélène Abel , Jean-Paul Barthès , Mathieu Hainselin
Telematics and Informatics, 2018, 35 (4), pp.913-929. ⟨10.1016/j.tele.2017.11.010⟩
Journal articles hal-01661708v1

Détermination des caractéristiques des erreurs médicamenteuses détectées par la conciliation médicamenteuse en rhumatologie

Amélie Boursier , Aurélien Mary , Franck Grados , Isabelle Desailly Henry , Aurélie Terrier Lenglet
Revue du Rhumatisme, 2018, 85 (3), pp.285-290. ⟨10.1016/j.rhum.2017.02.004⟩
Journal articles hal-03859610v1

Clinical impact of medication reconciliation at admission in a cardiac surgery unit

Mathilde Royer , Benjamin Valentin , Y. Hun , Joseph Nader , Thierry Caus
International Journal of Clinical Pharmacy, 2017, 39 (1), pp.244-245
Journal articles hal-03572342v1

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study

Aurelie Lenglet , Sophie Liabeuf , Najeh El Esper , Sandrine Brisset , Janette Mansour
Nephrology Dialysis Transplantation, 2017, 32 (5), pp.870-879. ⟨10.1093/ndt/gfw042⟩
Journal articles hal-03564976v1

Assessment of clinical practice: drug's prescriptions in hospitalized patients aged 75 years and older

L. Mondet , B. Marquant , I. Defouilloy , Aurélie Terrier-Lenglet , M. Belhout
Fundamental & Clinical Pharmacology, 2017, 31 (1, SI), pp.12
Journal articles hal-03584689v1
Image document

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients

Aurelien Mary , Agnes Hartemann , Sophie Liabeuf , Carole Elodie Aubert , Salim Kemel
Cardiovascular Diabetology, 2017, 16, ⟨10.1186/s12933-017-0509-7⟩
Journal articles hal-03555488v1

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study (vol 32, pg 870, 2017)

Aurelie Lenglet , Sophie Liabeuf , Najeh El Esper , Sandrine Brisset , Janette Mansour
Nephrology Dialysis Transplantation, 2017, 32 (9), pp.1597. ⟨10.1093/ndt/gfx249⟩
Journal articles hal-03564975v1
Image document

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells

Pauline Estupina , Alexandre Fontayne , Jean-Marc Barret , Nathalie Kersual , Olivier Dubreuil
Oncotarget, 2017, 8 (23), pp.37061-37079. ⟨10.18632/oncotarget.15715⟩
Journal articles hal-02379710v1

The clinical impact of treatment discrepancies recorded for 200 patients in an acute geriatric unit

P. Saint-Germain , M. Ruelle , Aurélien Mary , S. Sid Idris , S. Hannat
La Revue de Médecine Interne, 2016, 37 (10), pp.667-673. ⟨10.1016/j.revmed.2016.02.017⟩
Journal articles hal-03584690v1
Image document

N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin

Aurelie Lenglet , Sophie Liabeuf , Sandra Bodeau , Loïc Louvet , Aurelien Mary
Toxins, 2016, 8 (11), ⟨10.3390/toxins8110339⟩
Journal articles hal-03568256v1

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients

Rodrigo Bueno De Oliveira , Sophie Liabeuf , Hirokazu Okazaki , Aurélie Lenglet , Lucie Desjardins
Clinical Kidney Journal, 2013, 6 (1), pp.63-70. ⟨10.1093/ckj/sfs176⟩
Journal articles hal-04139795v1

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease

Lucie Desjardins , Sophie Liabeuf , Aurélie Lenglet , Horst-Dieter Lemke , Raymond Vanholder
Toxins, 2013, 5 (11), pp.2058-2073. ⟨10.3390/toxins5112058⟩
Journal articles hal-04139791v1

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?

Sophie Liabeuf , Griet Glorieux , Aurélie Lenglet , Momar Diouf , Eva Schepers
PLoS ONE, 2013, 8 (6), ⟨10.1371/journal.pone.0067168⟩
Journal articles hal-04139793v1

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients

Rodrigo B. De Oliveira , Sophie Liabeuf , Hirokazu Okazaki , Aurélie Lenglet , Lucie Desjardins
Nephrology Dialysis Transplantation, 2013, 28 (1), pp.165
Journal articles hal-04139794v1

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients

Aurélie Lenglet , Sophie Liabeuf , Pauline Guffroy , Albert Fournier , Michel Brazier
Drugs in R&D, 2013, 13 (3), pp.165-173. ⟨10.1007/s40268-013-0024-6⟩
Journal articles hal-04139792v1

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease

Nathalie Neirynck , Sunny Eloot , Griet Glorieux , Daniela V. Barreto , Fellype C. Barreto
PLoS ONE, 2012, 7 (8), ⟨10.1371/journal.pone.0044201⟩
Journal articles hal-04139798v1

Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients

Sophie Liabeuf , Aurélie Lenglet , Lucie Desjardins , Nathalie Neirynck , Griet Glorieux
Kidney International, 2012, 82 (12), pp.1297-1303. ⟨10.1038/ki.2012.301⟩
Journal articles hal-04139796v1

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages

L. Desjardins , S. Liabeuf , C. Renard , Aurélie Lenglet , H-D. Lemke
Osteoporosis International, 2012, 23 (7), pp.2017-2025. ⟨10.1007/s00198-011-1838-0⟩
Journal articles hal-04139799v1

Misuse of a Salbutamol Inhaler Causing Skin Burns

Aurélie Terrier-Lenglet , Houcine Chaib Derra , Catherine Devoldere , Valérie Dufour , Valerie Gras
Therapies, 2012, 67 (1), pp.59-61. ⟨10.2515/therapie/2012008⟩
Journal articles hal-04139713v1

Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease

Aurélie Lenglet , Sophie Liabeuf , Lucie Desjardins , Nathalie Neirynck , Griet Glorieux
The International Journal of Artificial Organs, 2012, 35 (11), pp.959-968. ⟨10.5301/ijao.5000124⟩
Journal articles hal-04139797v1

Prognostic Implication of Plasma Osteopontin Levels in Patients with Chronic Kidney Disease

Daniela V. Barreto , Aurélie Lenglet , Sophie Liabeuf , Axel Kretschmer , Fellype C. Barreto
Nephron Clinical Practice, 2011, 117 (4), pp.C363-C372. ⟨10.1159/000321520⟩
Journal articles hal-04139800v1

Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease

Aurélie Terrier-Lenglet , Aude Nollet , Sophie Liabeuf , Daniela V. Barreto , Michel Brazier
Néphrologie & Thérapeutique, 2011, 7 (4), pp.219-224. ⟨10.1016/j.nephro.2010.12.009⟩
Journal articles hal-04139714v1

Optimization of the treatment after stroke attack in the rehabilitation center: place of the pharmacist in a multidisciplinary team

Aurélie Lenglet , L. Lenne , L. Leteurtre , S. Bakhtaoui-Couriat , F. Perla
Pharmacy World and Science, 2009, 31 (2), pp.308
Journal articles hal-04139802v1

Pathological gambling and dopaminergic agonists

Aurélie Lenglet , V. Gras , A. Smail , P. Krystkowiak , I. Bonnet
Fundamental & Clinical Pharmacology, 2009, 23, pp.39
Journal articles hal-04139801v1